What is depression?
Clinical depression, also often referred to as major depressive disorder (MDD), is a mental health condition characterized by persistent and intense feelings of sadness, hopelessness, and a lack of interest or pleasure in activities. It goes beyond the typical ups and downs that people experience in their daily lives and can significantly impact a person’s thoughts, emotions, and overall ability to function.
Ketamine-assisted therapy has shown promise in the treatment of depression, particularly in cases where traditional treatments have been less effective. Ketamine is a dissociative anesthetic that has been used for many years in medical settings, primarily for anesthesia and pain management.
Psychotherapy, also known as talk therapy or counseling, is a well-established and effective treatment for depression. There are different types of psychotherapy, and they can be used alone or in combination with other treatments such as medication. We offer group psychotherapy as an option for our patients due to it's social advantages, including an increased sense of belonging and camaraderie among participants, openness and discussion to explore and hear different perspectives, creation of accountability, confidence and self discovery. Integration sessions build increased trust, connections and community.
Repetitive Transcranial Magnetic Stimulation (rTMS) is a non-invasive medical treatment that has been approved by regulatory authorities in various countries, including the U.S. Food and Drug Administration (FDA), for the treatment of major depressive disorder (MDD), especially in individuals who have not responded well to other therapies. It is non-invasive and allows for targeted treatment.
Health Canada’s Special Access Program enables the use of certain psychedelic substances that are not marketed in Canada as requested by practitioners. Access is typically granted for treating, diagnosing, or preventing serious or life-threatening conditions when conventional therapies or medications have failed. Individuals with treatment-resistant or major depressive disorder may qualify for access to psilocybin through the SAP.
If any of this strikes a chord for you or for a loved one, please take some time to reflect on these considerations before reaching out to us to book an Info Session. From there, we can support you in determining whether one of our treatments could be right for you, and how to begin your healing journey with Cena Life.